SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.17847452 USD and is down -3.32 over the last 24 hours. It is currently trading on 1894 active market(s) with $2,362,443,159.56 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sustained weakness and underperformance amid a broader crypto selloff are driving discussion, with traders also concerned that political uncertainty could delay the CLARITY Act. Many blame Ripples token supply and question XRPs utility, while others view the decline as a buying opportunity and continue accumulating.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs better-than-expected quarterly results and raised full-year revenue outlook sparked a sharp rally, with traders also pointing to growing backlog and quantum-computing demand. The upbeat reaction is tempered by debate over how much growth came from the SkyWater acquisition, as well as concerns about cash burn, dilution, and whether the gap-up can hold.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Debate over Snowflakes consumption-based model is driving attention, with traders warning that tighter budgets could lead customers to cut queries, storage and AI workloads, pressuring usage-linked revenue. Others see the models flexibility as a source of recovery when spending improves, while dip buyers and bearish traders remain divided on the stocks direction.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertivs stronger-than-expected quarterly results, raised outlook and more than doubled organic orders sparked a sharp rally, reinforcing optimism about demand for its data-center power and cooling systems. Some traders see confirmation that AI infrastructure spending remains robust, while skeptics point to permitting delays, financing risks and uncertainty over whether orders will translate into delivered revenue.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is drawing scrutiny over whether AI agents can grow revenue when they may also reduce the employee seats its traditional software pricing depends on. Traders are debating whether customers will pay for AI add-ons at renewal or instead cut seats and software spending, amid a broader selloff in enterprise software.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins sharp, volatile selloff is driving attention to Strategy as a leveraged BTC proxy, with traders debating whether the weakness could deepen the stocks losses. Bears also cite dilution, preferred-stock obligations and a possible MSCI removal as risks, while bulls argue the pullback is a buying opportunity and look for a rebound.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Aristas strong quarterly results and better-than-expected outlook, tied to demand for AI data-center networking, are driving attention and a sharp post-earnings rally. Bulls welcomed the growth and guidance, while others questioned whether hyperscaler spending can sustain it and warned of valuation-related profit-taking and volatility.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladocs post-earnings rally is drawing attention as traders focus on improved profitability and cash generation, along with managements ability to address upcoming debt with cash rather than dilution. Bulls see a potential turnaround and speculate about a short squeeze, while skeptics point to declining revenue and continued weakness at BetterHelp.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is drawing attention after quarterly results beat expectations, with Alani Nu growth and international expansion offsetting a decline in the flagship Celsius brand. Traders welcomed the beat and stock rebound, but some question how durable the growth is and point to weaker core-brand sales and compressed margins.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewys post-earnings selloff is dominating discussion: traders point to soft organic growth, margin concerns and weaker quarterly free cash flow despite a raised full-year sales outlook. Bulls view the drop as an overreaction to a still-profitable business, while bears see persistent consumer weakness and limited growth as reasons for caution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ALT Q1 &#39;25 Earnings Results &amp; Recap

Altimmune&#39;s Q1 &#39;25 EPS of -$0.26 exceeded the -$0.35 estimate, while revenue remained at 0M as expected; the company anticipates positive Phase 2b trial results, but faces financial challenges despite a new $100M credit facility.

Ben Fowler

Noah Portillo

StockTwits Web

Bobby Hatton

$ALT the estimate was -$0.35, not $0.35. So isnt the actual EPS of -$0.26 a positive? Not a negative?

Michael Gutierrez

Stocktwits

Altimmune Inc

 Q1 '25 Earnings Results & Recap

Altimmune's Q1 '25 EPS of -$0.26 exceeded the -$0.35 estimate, while revenue remained at 0M as expected; the company anticipates positive Phase 2b trial results, but faces financial challenges despite a new $100M credit facility.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Patricia

@StocktwitsEarnings I&#39;m gonna send this shit to the SEC !

@StocktwitsEarnings I see stocktwits is still helping spread FUD against this small caps biotech. Their collusion on paid Fear, Uncertainty, and Doubt is all being documented and sent to the SEC for immediate investigation.

 I see stocktwits is still helping spread FUD against this small caps biotech. Their collusion on paid Fear, Uncertainty, and Doubt is all being documented and sent to the SEC for immediate investigation.

Jim Patrick

@StocktwitsEarnings &quot;The Q1 &#39;25 earnings report shows a net loss of $19.6 million (-$0.26/share), exceeding the -$0.35 EPS estimate, but still reflecting ongoing operational losses.&quot; 
 
what? did recently dumbed down ChatGPT write this?

 "The Q1 '25 earnings report shows a net loss of $19.6 million (-$0.26/share), exceeding the -$0.35 EPS estimate, but still reflecting ongoing operational losses." 
 
what? did recently dumbed down ChatGPT write this?

Justin Smith

@StocktwitsEarnings Along with the blatant incorrectness that has already been noted by others, you might look even a little more credible if you even got the drug name correct as well SMH it is PEMVIDUTIDE.

StockTwits for iOS

 Along with the blatant incorrectness that has already been noted by others, you might look even a little more credible if you even got the drug name correct as well SMH it is PEMVIDUTIDE.

Jennifer

@StocktwitsEarnings ST loves to lie and can barely speak English.

 ST loves to lie and can barely speak English.

Steve Graves

@StocktwitsEarnings ST would be better off if they stopped being for sale to the highest bidder.

 ST would be better off if they stopped being for sale to the highest bidder.

Michael Moore

@StocktwitsEarnings $PREDICT $ROAST  
$ALT Altimmune downgraded and new PT assigned followed concerning Q1 Earnings Call.  
 
BioRich Capital has downgraded Altimmune to a &quot;Strong Sell&quot; and 1-year PT of $2.69.   
 
Factors contributing to this target include: 
1) Company History and Management Business Practices. 
2) Concerns Regarding Company&#39;s Financial Position. 
3) Company-related Data Integrity Concerns. 
4) Discontinuation of Obesity Program. 
5) Uncertainty related to pending and future data readouts. 
6) Company&#39;s approach and engagement with the FDA. 
7) Increased and improvement in competition. 
8) Long periods of data drought ahead.  
9) Current SP inflated. 
10) Lack of trust in company (MAJOR RED FLAG). 
 
After thorough technical analysis, a one-year PT of $2.69 appears relevant.  As this represents an ~55% decline from today&#39;s opening SP, a &quot;Strong Sell&quot; rating has been applied. 
 
Follow/Subscribe for more suggestions and perspective. 
Cheers! 
 
$XBI $SPY

StockTwits Predictions

SPDR S&P Biotech ETF

 Altimmune downgraded and new PT assigned followed concerning Q1 Earnings Call.  
 
BioRich Capital has downgraded Altimmune to a "Strong Sell" and 1-year PT of $2.69.   
 
Factors contributing to this target include: 
1) Company History and Management Business Practices. 
2) Concerns Regarding Company's Financial Position. 
3) Company-related Data Integrity Concerns. 
4) Discontinuation of Obesity Program. 
5) Uncertainty related to pending and future data readouts. 
6) Company's approach and engagement with the FDA. 
7) Increased and improvement in competition. 
8) Long periods of data drought ahead.  
9) Current SP inflated. 
10) Lack of trust in company (MAJOR RED FLAG). 
 
After thorough technical analysis, a one-year PT of $2.69 appears relevant.  As this represents an ~55% decline from today's opening SP, a "Strong Sell" rating has been applied. 
 
Follow/Subscribe for more suggestions and perspective. 
Cheers! 
 


The Legendary Mayor

@StocktwitsEarnings you’ve been reported